Topical Glucocorticoids with Improved Risk-Benefit Ratio
- 1 June 1996
- journal article
- review article
- Published by Springer Nature in Drug Safety
- Vol. 14 (6) , 375-385
- https://doi.org/10.2165/00002018-199614060-00003
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Moderne topische Glukokortikoide und Antiinfektiva beim superinfizierten atopischen Ekzem: Bilden Prednicarbat und Dodecyldimethylammoniumchlorid eine rationale Kombination?Infection, 1994
- Analysis of the DNA-binding affinity, Sequence Specificity and Context Dependence of the Glucocorticoid Receptor Zinc Finger RegionJournal of Molecular Biology, 1994
- Morphometric studies of the localization of the glucocorticoid receptor in mammalian cells and of glucocorticoid hormone-induced effects.Journal of Histochemistry & Cytochemistry, 1994
- Topical Corticosteroids and Unwanted Local EffectsDrug Safety, 1994
- Comparison of the local and systemic side effects of methylprednisolone aceponate and mometasone furoate applied as ointments with equal antiinflammatory activityJournal of the American Academy of Dermatology, 1993
- Small reduction of capsaicin-induced neurogenic inflammation in human forearm skin by the glucocorticoid prednicarbateInflammation Research, 1993
- Systemic effects of topically applied methylprednisolone aceponate in healthy volunteersJournal of the American Academy of Dermatology, 1993
- Topical glucocorticoids with improved benefit/risk ratio: Do they exist?Journal of the American Academy of Dermatology, 1992
- Dose-response relationship of topically applied methylprednisolone aceponate (MPA) in healthy volunteersEuropean Journal of Clinical Pharmacology, 1992
- Binding affinities of rimexolone (ORG 6216), flunisolide and their putative metabolites for the glucocorticoid receptor of human synovial tissueInflammation Research, 1990